Skip to main content
NVDA-0.17%AAPL-0.43%GOOGL-0.73%MSFT+0.58%AMZN-0.82%TSM+1.26%SPCX+1.68%META-0.73%AVGO+0.32%TSLA-0.63%LLY-3.46%BRK-B-0.99%MU+3.06%SKHY+4.21%WMT-1.51%JPM-1.31%AMD+2.03%V-1.19%XOM+2.29%JNJ-1.62%ASMLa-0.87%MA-1.68%ABBV+0.31%CVX+2.47%INTC+1.73%0700.HK+0.94%COST-1.36%1398.HK-1.50%CSCO+1.36%KO-2.54%ORCL+1.84%UNH-1.73%PG-2.47%BAC-0.73%1816.HK+0.44%3988.HK-0.50%HD-2.72%CAT-2.26%0005.HK-1.04%PM-0.80%HSBA.L-1.40%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT+0.83%GE-2.19%1288.HK-1.94%NVS-4.15%DELL+1.62%LRCX+0.09%EURAUD-1.66%AUDCHF+1.42%EURCAD-1.40%AUDUSD+1.28%EURNZD-1.22%CADCHF+1.15%EURJPY-1.09%USDCAD-1.00%NZDCHF+0.98%GBPAUD-0.95%USDTHB+0.94%CHFJPY-0.88%NZDUSD+0.84%USDPLN+0.77%USDJPY-0.73%EURGBP-0.72%PLNJPY-0.71%GBPCAD-0.70%CHFNOK-0.62%AUDJPY+0.60%USDZAR+0.59%EURPLN+0.58%GBPNZD-0.53%CHFSGD-0.49%GBPCHF+0.45%AUDNZD+0.45%USDTRY+0.43%GBPTRY+0.41%EURZAR+0.41%AUDDKK+0.40%GBPJPY-0.39%EURUSD-0.39%GBPZAR+0.39%NZDSGD+0.38%GBPUSD+0.33%GBPHKD+0.32%AUDSGD+0.30%CADJPY+0.30%EURCZK+0.29%CHFSEK-0.29%USDSEK+0.29%USDMXN-0.29%GBPMXN-0.28%AUDCAD+0.28%EURCHF-0.25%USDCNH-0.24%EURNOK-0.24%EURCNH-0.23%USDDKK+0.18%AUDNOK+0.17%NZDCAD-0.16%USDILS+0.16%USDCHF+0.13%GBPSGD-0.12%NOKJPY+0.12%NZDJPY+0.11%EURSGD-0.11%EURSEK+0.10%EURHKD-0.09%USDSGD+0.08%USDNOK-0.06%USDHKD-0.05%USDCOP-0.04%SGDJPY-0.02%EURDKK-0.01%NZDMXN0.00%USOIL+3.89%XNGUSD-2.93%UKOIL+2.67%HG1+1.61%GAGUSD-1.05%XAGUSD-1.05%XAUUSD-0.62%GAUUSD-0.61%XPTUSD-0.38%C10.00%COFFEE0.00%COCOA0.00%BTCUSD+0.22%ETHUSD+20.55%USDTUSD+0.02%XRPUSD+14.70%SOLUSD+14.32%TRXUSDT+0.59%ZECUSDT+2.48%DOGEUSD+19.00%XMRUSDT-1.28%LINKUSD+19.73%XLMUSD+0.66%BCHUSDT+4.00%UNIUSD+2.44%LTCUSD+13.73%SUIUSD+1.80%HBARUSDT-1.18%TONUSD+30.40%TAOUSDT+1.31%AAVEUSD+1.14%DOTUSDT+1.35%ICPUSDT+2.80%WLDUSDT-3.71%ONDOUSDT+0.42%ARBUSDT+1.17%JUPUSDT-0.30%ATOMUSDT+2.87%INJUSDT-0.32%STXUSDT+0.50%TIAUSDT-0.66%FETUSDT+1.79%PYTHUSDT+1.29%SEIUSDT+2.60%IMXUSDT+2.21%GRTUSDT+0.89%OPUSDT+0.74%WIFUSDT-0.15%IOTAUSDT-0.24%POLUSDT+1.19%AXSUSDT+1.22%FARTCOINUSDT+0.68%EOSUSDT-1.54%DYDXUSDT+1.34%GALAUSDT+1.41%ORDIUSDT+1.71%RONINUSDT+0.24%NOTUSDT+3.13%NVDA-0.17%AAPL-0.43%GOOGL-0.73%MSFT+0.58%AMZN-0.82%TSM+1.26%SPCX+1.68%META-0.73%AVGO+0.32%TSLA-0.63%LLY-3.46%BRK-B-0.99%MU+3.06%SKHY+4.21%WMT-1.51%JPM-1.31%AMD+2.03%V-1.19%XOM+2.29%JNJ-1.62%ASMLa-0.87%MA-1.68%ABBV+0.31%CVX+2.47%INTC+1.73%0700.HK+0.94%COST-1.36%1398.HK-1.50%CSCO+1.36%KO-2.54%ORCL+1.84%UNH-1.73%PG-2.47%BAC-0.73%1816.HK+0.44%3988.HK-0.50%HD-2.72%CAT-2.26%0005.HK-1.04%PM-0.80%HSBA.L-1.40%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT+0.83%GE-2.19%1288.HK-1.94%NVS-4.15%DELL+1.62%LRCX+0.09%EURAUD-1.66%AUDCHF+1.42%EURCAD-1.40%AUDUSD+1.28%EURNZD-1.22%CADCHF+1.15%EURJPY-1.09%USDCAD-1.00%NZDCHF+0.98%GBPAUD-0.95%USDTHB+0.94%CHFJPY-0.88%NZDUSD+0.84%USDPLN+0.77%USDJPY-0.73%EURGBP-0.72%PLNJPY-0.71%GBPCAD-0.70%CHFNOK-0.62%AUDJPY+0.60%USDZAR+0.59%EURPLN+0.58%GBPNZD-0.53%CHFSGD-0.49%GBPCHF+0.45%AUDNZD+0.45%USDTRY+0.43%GBPTRY+0.41%EURZAR+0.41%AUDDKK+0.40%GBPJPY-0.39%EURUSD-0.39%GBPZAR+0.39%NZDSGD+0.38%GBPUSD+0.33%GBPHKD+0.32%AUDSGD+0.30%CADJPY+0.30%EURCZK+0.29%CHFSEK-0.29%USDSEK+0.29%USDMXN-0.29%GBPMXN-0.28%AUDCAD+0.28%EURCHF-0.25%USDCNH-0.24%EURNOK-0.24%EURCNH-0.23%USDDKK+0.18%AUDNOK+0.17%NZDCAD-0.16%USDILS+0.16%USDCHF+0.13%GBPSGD-0.12%NOKJPY+0.12%NZDJPY+0.11%EURSGD-0.11%EURSEK+0.10%EURHKD-0.09%USDSGD+0.08%USDNOK-0.06%USDHKD-0.05%USDCOP-0.04%SGDJPY-0.02%EURDKK-0.01%NZDMXN0.00%USOIL+3.89%XNGUSD-2.93%UKOIL+2.67%HG1+1.61%GAGUSD-1.05%XAGUSD-1.05%XAUUSD-0.62%GAUUSD-0.61%XPTUSD-0.38%C10.00%COFFEE0.00%COCOA0.00%BTCUSD+0.22%ETHUSD+20.55%USDTUSD+0.02%XRPUSD+14.70%SOLUSD+14.32%TRXUSDT+0.59%ZECUSDT+2.48%DOGEUSD+19.00%XMRUSDT-1.28%LINKUSD+19.73%XLMUSD+0.66%BCHUSDT+4.00%UNIUSD+2.44%LTCUSD+13.73%SUIUSD+1.80%HBARUSDT-1.18%TONUSD+30.40%TAOUSDT+1.31%AAVEUSD+1.14%DOTUSDT+1.35%ICPUSDT+2.80%WLDUSDT-3.71%ONDOUSDT+0.42%ARBUSDT+1.17%JUPUSDT-0.30%ATOMUSDT+2.87%INJUSDT-0.32%STXUSDT+0.50%TIAUSDT-0.66%FETUSDT+1.79%PYTHUSDT+1.29%SEIUSDT+2.60%IMXUSDT+2.21%GRTUSDT+0.89%OPUSDT+0.74%WIFUSDT-0.15%IOTAUSDT-0.24%POLUSDT+1.19%AXSUSDT+1.22%FARTCOINUSDT+0.68%EOSUSDT-1.54%DYDXUSDT+1.34%GALAUSDT+1.41%ORDIUSDT+1.71%RONINUSDT+0.24%NOTUSDT+3.13%
LT

Lexeo Therapeutics, Inc. Common Stock (LXEO)

NASDAQ • Healthcare

$2.89
-$0.1 (-3.7%)
Market open

Last close at October 22, 2026 at 20:00 UTC

Open$2.98
Previous Close$2.89
Day Range$2.89 - $3.12
Avg. Volume (3M)1.9M
Market Cap$226.6M
52 Week Range
$2.55$10.99
Next EarningsIn 52 daysDec 14, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$87.2M
EPS (TTM)
-$1.15
ROA (TTM)
-34.24%
Current Ratio
13.89

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+15.6%Q1 2026-$0.27
+13.8%Q2 2026-$0.25
-5.2%Q3 2026-$0.3
Next

Dec 14

in 52 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -5.2%

Lexeo Therapeutics’ preliminary second fiscal quarter of 2026 results, reported Aug. 12, missed EPS consensus, with a loss of $0.30 per share versus a $0.29 estimate, -5%. Based on preliminary results, EPS of -$0.30 was up 50% from a $0.60 loss a year ago, and net income came in at a loss of about $25.9 million, up 1% from a $26.1 million loss a year earlier. Operating income was a loss of roughly $28.0 million, and operating cash flow was negative $17.6 million. Consensus for the next period calls for EPS of -$0.32.

View full earnings history

About Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. is a clinical-stage Biotechnology company listed on NASDAQ as LXEO. The company develops gene therapies for genetically defined cardiovascular and neurologic diseases, with a pipeline centered on inherited cardiomyopathies, APOE4-targeted programs, and CLN2 Batten disease in patients with rare, mutation-linked disorders.

Name
Lexeo Therapeutics, Inc. Common Stock
CEO
R. Nolan Townsend
Website
www.lexeotx.com
Industry
Healthcare
Year Founded
2017
Employees
63

Today's Snapshot

AI-generated

LXEO is trading 3.2% below yesterday's close, in line with a weaker sector.

Trading Volume

Below 10d avg (1.3M)

169.3K

vs S&P 500 Today

Strong Underperformance

-3.00%

Updated: October 23, 2026 at 16:57 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
LXEO displays a strong sell characterization driven by a clear downtrend and weak internals: ADX is elevated at 33.09 indicating trend strength while momentum readings are negative and oscillators sit into lower ranges, signaling weak buying interest. The current price of 2.7854 is substantially below longer-term moving averages and just under the pivot at 2.97, reflecting persistent downside bias. Volatility is high with ATR near 9.12%, and OBV is negative, pointing to selling pressure on volume. Technical takeaway: Strong Sell — trending weakness and negative volume dominate the technical picture.
All signals
  • EMA (5 indicators)$2.92 - $5.60
    Sell
  • RSI (14)34.86
    Neutral
  • Stochastic %K (14, 3, 3)31.90
    Neutral
  • MACD Level (12, 26)-0.31
    Neutral

Peers & Related Assets

CAPRCapricor Therapeutics, Inc.
$6.13+4.3%
VNDAVanda Pharmaceuticals Inc.
$4.05+1.0%
LRMRLarimar Therapeutics, Inc.
$2.27-6.2%
VYGRVoyager Therapeutics, Inc.
$1.86-7.9%
SLNSilence Therapeutics plc
KYTXKyverna Therapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.